HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

AMG 386

a selective angiopoietin 1/2-neutralizing peptibody
Also Known As:
AMG-386; AMG386
Networked: 26 relevant articles (4 outcomes, 16 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Sun, Yu-Nien: 8 articles (06/2015 - 07/2009)
2. Rasmussen, Erik: 4 articles (06/2015 - 07/2009)
3. Wu, Benjamin: 3 articles (10/2015 - 04/2012)
4. Vergote, Ignace B: 3 articles (09/2013 - 02/2012)
5. Karlan, Beth Y: 3 articles (09/2013 - 02/2012)
6. Weinreich, David M: 3 articles (01/2013 - 02/2012)
7. Oliner, Jonathan D: 3 articles (04/2012 - 07/2009)
8. Navale, Lynn: 2 articles (10/2015 - 05/2012)
9. Ravaud, Alain: 2 articles (10/2015 - 12/2012)
10. Tomczak, Piotr: 2 articles (10/2015 - 12/2012)

Related Diseases

1. Neoplasms (Cancer)
2. Ovarian Neoplasms (Ovarian Cancer)
3. Renal Cell Carcinoma (Grawitz Tumor)
4. Carcinoma (Carcinomatosis)
5. Disease Progression

Related Drugs and Biologics

1. TIE-2 Receptor (Receptor, TIE 2)
2. Angiopoietin-1
3. Cisplatin (Platino)
4. capecitabine (Xeloda)
5. Paclitaxel (Taxol)
6. Angiopoietins
7. bevacizumab
8. Angiopoietin-2
9. Epidermal Growth Factor Receptor (EGF Receptor)
10. Protein-Tyrosine Kinases (Tyrosine Kinase)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Heterologous Transplantation (Xenotransplantation)
3. Stents
4. Therapeutics
5. Lasers (Laser)